key: cord-0904742-nl7d3wxe
authors: Dixon, Joseph; Mirtorabi, Negin; Cutteridge, Joseph; Karia, Monil; Pollard, Thomas
title: A Safety Evaluation of the Resumption of Elective Orthopaedic Services in Higher Risk Patients During the COVID-19 Pandemic
date: 2022-02-17
journal: Cureus
DOI: 10.7759/cureus.22339
sha: 64cc32ed687d12a88973fabd74e2aa3657599062
doc_id: 904742
cord_uid: nl7d3wxe

Introduction The COVID-19 pandemic has caused mass disruption to all aspects of society, with elective orthopaedics not spared. The pandemic has the potential to cause a tsunami of health burden in the community if elective services are not resumed to pre-pandemic levels of activity. Studies have shown that elective orthopaedics can be safely carried out in a COVID-19 free hospital. This study reviewed the transition in operating at an independent COVID-19 free hospital to an NHS hospital concurrently treating patients with COVID-19. Methods A strategy of phased relaxation of clinical comorbidity criteria was followed. Patients from the orthopaedic waiting list were selected according to these criteria and observed recommended preoperative isolation protocols. Operations were undertaken in the independent sector under the COVID-19 contract and the NHS site. Patients were assessed from all phases in the resumption of services. In-hospital and post-operative complications with specific enquiries regarding the development of COVID-19 symptoms or the need and outcome for COVID-19 testing at 14 days and six weeks was recorded. Results This study included 263 patients, of which 155 were female. The mean age of patients was 52.45. The mean BMI of all patients was 29.1 kg/m2. Additionally, 124 patients were American Society of Anesthesiologists (ASA) grade 1, 117 ASA grade 2 and 22 ASA grade 3 and 167 patients underwent a major operation, with total hip replacement being the most common operation. There were no in-hospital complications. No patients had a positive test result or symptoms of COVID-19 in the six-week post-operative period. Conclusion In summary, we demonstrated that elective orthopaedic surgery can be safely undertaken via a green pathway in a higher risk patient cohort when COVID-19 is prevalent in the community.

The SARS-CoV-2 (COVID-19) pandemic caused mass disruption to all aspects of society, with elective orthopaedics not spared. An estimated 516,000 planned operations were cancelled in the first wave of the pandemic in the United Kingdom (UK) [1] . Orthopaedic departments in the UK currently face a challenging situation with significant staff absences due to high numbers of positive COVID-19 cases set against a background of vastly expanded waiting lists [2] [3] [4] [5] . Figures from the British Orthopaedic Association (BOA) show the total waiting list for trauma and orthopaedics in England now stands over 704,000 patients, with over 63,000 patients waiting over one year to begin treatment [4] . These figures have increased significantly over the last 12 months with a 30% increase in the number of patients waiting over two years for an operation. Orthopaedics had the second-lowest return to the expected capacity of inpatient planned care [6] . Another barrier to resuming elective care are patient concerns with regards to undergoing surgery during a pandemic with studies showing only 56% of patients wished to proceed with planned orthopaedic care [7] . These figures were mirrored in our department when patients were initially contacted at the onset of the pandemic [8] . However, deferring the burden of chronic musculoskeletal conditions will not make it go away. Many individuals awaiting joint replacement surgery have a severely reduced quality of life, enduring significant amounts of pain and suffering, described by some patients as a state 'worse than death' [9] .

A previous study from our trauma and orthopaedics department at Royal Berkshire NHS Foundation Trust showed that elective orthopaedic services can be safely resumed in the independent sector at a time when COVID-19 is prevalent in the community with high levels of patient satisfaction with no COVID-19 related complications [8] . The previously published study was limited to a low-risk patient cohort, with all patients being American Society of Anesthesiologists (ASA) grade 1, indicating an otherwise healthy individual (8) . The patient cohort for the previously published work was selected as they were deemed to be at the lowest risk of developing significant complications of COVID-19 post-operatively [10] . Operations were undertaken at designated green hospital sites (COVID-19 free) in the independent sector. Herein we review the transition period from operating in the Independent sector to elective orthopaedic operating at the National Health Service (NHS) District General Hospital (DGH) site. We will also assess the outcomes of patients with higher ASA grades.

Elective surgery at our trust was paused from the 17th March 2020 to allow our theatres to be converted into an intensive care facility in preparation for the surge in COVID-19 admissions. Elective surgery was reintroduced on 4th May 2020 in the independent sector with strict clinical criteria. Phase 1 documented the first 100 patients to undergo surgery under the new COVID-19 precautions. Patients were prospectively monitored for symptoms of COVID-19 or post-operative complications at 14 days. None of the first 100 patients required re-admission to the hospital for any complication. A single patient tested positive for COVID-19. The results from phase 1 have been published and demonstrated a safe process with high levels of patient satisfaction with the process [8] . Therefore, it was judged that the protocol was safe to progress to phases 2,3 and 4 of the re-start of elective orthopaedic procedures, with each successive phase reducing patient exclusion criteria ( Table 1) .

The four principles of staff, space, stuff and systems were considered throughout the process of re-starting to ensure the safety of our patients and staff. The clinical criteria for patient selection were based on the best available evidence at the time and were reviewed throughout [10] [11] [12] [13] . For phases 1-4, the pre-operative patient and household isolation period was set at 14 days; however, this was later reduced to three days on the 3rd August 2020 for lower-risk patients as per instructions from Public Health England. For low-risk patients in phase 4, the isolation period was optional. Any patient with a positive SARS-CoV-2 RT-PCR test preoperatively or symptoms of COVID-19 had their operation postponed. Elective operating returned to our NHS DGH site on 3rd August 2020 (phase 4). The designated green pathways as implemented in the independent sector were followed. Patients were admitted to ring-fenced green zone beds and were operated on in designated green zone theatres. Staff would be posted in the green zone for the entirety of the working day to limit transmission. 

Patients identified as eligible at each phase entered the preoperative assessment pathway previously published [8] . Patients were isolated along with their household prior to their surgical date, although household contacts were allowed to make essential journeys provided they followed government guidance at that time. Five days prior to surgery patients underwent preoperative assessment, including routine methicillin-sensitive Staphylococcus aureus (MSSA) swabbing for those undergoing prosthetic surgery, and screening questions related to COVID-19 symptoms. All patients had a SARS-CoV-2 RT-PCR test (nasopharyngeal and throat swab) 48 to 72 hours preoperatively and were provided with an information leaflet explaining the measures taken by the hospital to protect them from contracting COVID-19 [14] .

On arrival at the hospital, all patients had their temperature checked and were screened for infection with a questionnaire. Patients were anaesthetised and extubated in theatre with just the anaesthetist and operating department practitioner (ODP) present. After the patient left the theatre, there was a five-minute delay prior to cleaning, to allow sufficient air changes. Upon discharge, patients were advised to isolate as per Public Health England recommendations. At the onset of the study, periodic regular staff testing had not been introduced; however, this was introduced from August 2020 with weekly PCR tests. Staff were advised to follow national guidance if they developed symptoms or tested positive.

All patients undergoing elective surgery were surveyed via telephone at 14 days and followed up within six weeks post-surgery. The period of 14 days was selected as this reflected the period in which a patient who had acquired COVID-19 through nosocomial transmission would have been expected to develop symptoms. The six-week period was selected as representing a period of potential post-surgical immunosuppression with a potential higher risk of community-acquired COVID-19 infection. All patients underwent surgery between 4 May and 14 August 2020. The study was registered locally as a service evaluation.

In this study, there were a total of 263 patients, of which 155 were female and 108 were male. 

There were no in-hospital complications. No patients had a positive test result or symptoms of COVID-19 in the six-week post-operative period. A patient from phase 4 had to return to the hospital for investigation of a DVT which was negative, and one patient re-presented to the hospital following a seizure. None of these patients had symptoms of COVID-19 and all were discharged without a test.

No patients developed symptoms of COVID-19 or received a positive test result during the transition period. Patients were also asked if any family members had developed COVID-19 symptoms during the postoperative period, in order to screen for transmission from asymptomatic carriers. The was no difference in risk of complication or developing symptomatic COVID-19 infection for patients operated in the Independent sector or NHS hospital site.

This study included a higher risk cohort of patients who are more suspectable to severe disease and death from COVID-19 [15] . None of these patients (ASA grade 3) developed signs or symptoms of COVID-19 or had a positive test result. If these patients had contracted COVID-19 in hospital, none of them became symptomatic enough to require medical treatment or re-admission to hospital.

This study has shown that major orthopaedic operations can be performed safely in an NHS DGH during a period in which COVID-19 is prevalent in the community, with low levels of complications. Patients classified in higher ASA grades, who are thought to be at higher risk of developing COVID-19 complications post-operatively, were protected from infection and recovered well [15] [16] [17] . Our trust was able to achieve satisfactory patient outcomes in the six-week post-operative period with no patients readmitted to the hospital within the study period.

Studies have estimated that the probability of an asymptomatic patient with SARS-CoV-2 receiving a false negative preoperative test was 0.07% (around 1 in 1,400) [18] . The risk of a patient with an undetected infection being admitted for surgery and subsequently dying from the COVID-19 disease is estimated at approximately 1 in 7000 [18] . This information and the results of this study should re-assure patients that elective orthopaedic surgery can be safely provided via a green pathway at an NHS site.

This study has highlighted that Royal Berkshire NHS Foundation Trust was able to safely transition to elective operating at the main NHS DGH without resulting in adverse patient outcomes during this transition. There was a low transmission rate of COVID-19 in this study, with no positive test results from phase 2 of the resumptions of elective services.

There was no increase in transmission or complication rate for patients who were operated on in the COVID-19 free Independent sector or at the NHS site which was concurrently accepting patients with COVID-19. This should provide reassurance to patients and clinicians alike, especially in light of previous reports published at the outset of the pandemic, which demonstrated very high complication rates in patients undergoing operations when diagnosed with COVID-19 [17] .

The UK vaccination programme is has made excellent progress with 84% of the population over 12 years old having had two doses of the vaccine [19] . COVID-19 however remains prevalent in the community with novel variants frequently arising. The protection that the vaccines will provide against new variants is unknown.

The authors acknowledge limitations to this study, patients were not routinely tested for COVID-19 in the immediate post-operative period, so there is a possibility that some acquired asymptomatic COVID-19 infection in the community.

A second limitation of this study was, in phase 2 and 3, the continued requirement of the independent sector to provide a green site to operate on COVID-19 negative patients. Having a designated COVID-19 free site is unlikely to be a practical solution for many departments.

In summary, our trust has demonstrated that elective orthopaedic surgery can be safely undertaken via a green pathway when COVID-19 is prevalent in the community. This study has shown no greater risk of readmission in patients with higher ASA grades which should provide reassurance to trusts and patients that it is safe to return to pre-pandemic levels of elective orthopaedic surgery.

Human subjects: Consent was obtained or waived by all participants in this study. Royal Berkshire Hospital Trauma And Orthopaedic Department issued approval N/A. No ethical approval was required for this project as it was a service evaluation. It was registered locally with the hospital and audit department. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Elective surgery cancellations due to the COVID-19 pandemic: global predictive modelling to inform surgical recovery plans

The impact of the COVID-19 pandemic on orthopaedic services and training in the UK

NHS. Statistics: COVID-19 hospital activity

provisional statistics -NHS digital

Progress on restarting elective orthopaedic surgery

Restarting elective orthopaedic services during the COVID-19 pandemic: Do patients want to have surgery

Safety evaluation of a strategy to restart elective orthopaedic surgery during the de-escalation phase of the COVID-19 pandemic

Worse than death' and waiting for a joint arthroplasty

Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis

Impact of the COVID-19 pandemic on patients suffering from musculoskeletal tumours

Resuming elective orthopaedic surgery during the COVID-19 pandemic: guidelines developed by the International Consensus Group (ICM)

Information, guidance and resources for Coronavirus (COVID-19)

Obesity as a risk factor for severe COVID-19 and complications: a review

IMPACT-Restart: the influence of COVID-19 on postoperative mortality and risk factors associated with SARS-CoV-2 infection after orthopaedic and trauma surgery

Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection

The theoretical mortality risk of an asymptomatic patient with a negative SARS-CoV-2 test developing COVID-19 following elective orthopaedic surgery